BlueWillow Biologics Stock

bluewillow.comHealthcareFounded: 2000Funding to Date: $31.34MM

BlueWillow Biologics (also known as NanoBio) are the developer of intranasal vaccines that help protect global populations from food allergies, sexually transmitted diseases and respiratory infections. This company was founded in 2000 by James Baker and is headquartered in Ann Arbor, MI. BlueWillow's antiseptic and anti-infective products as well as NanoVax are using a patented nanotechnology platform to administrate nano-droplets to the skin and nose.

Register for Details

For more details on financing and valuation for BlueWillow Biologics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for BlueWillow Biologics.

Register Today

BlueWillow Biologics investors also invested in these private companies

Bill & Melinda Gates Foundation
National Institute of Allergy and Infectious Diseases
North Coast Technology Investors
Small Business Innovation Research

Team

Management Team

James Baker
Founder
George Arida
Chief Operating and Financial Officer
Chad Costley
Chief Executive Officer

Other companies like BlueWillow Biologics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B